<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-91120" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Drug Clearance</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Horde</surname>
            <given-names>Gaither W.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gaither Horde declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-91120.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Understanding the concept of drug clearance is essential when determining the dosing of medications. When a medication is administered intravenously, the drug ends up either in the blood plasma or redistributes into the extravascular volume. The drug present in the plasma can be removed from the body primarily through the kidneys and liver.&#x000a0;Drug clearance is defined as the volume of plasma cleared of a drug over a specified time period.<xref ref-type="bibr" rid="article-91120.r1">[1]</xref>&#x000a0;Thus, the unit of measurement for drug clearance is volume/time. Another equation can calculate clearance.&#x000a0;Clearance is equal to the rate at which a drug is removed from plasma(mg/min) divided by the concentration of that drug in the plasma (mg/mL). The total ability of the body to clear a drug from the plasma is renal clearance plus hepatic clearance plus clearance from all other tissues. It is important to be aware of the fact that clearance does not tell us the amount of drug cleared. For example, let&#x02019;s say drug X has a renal clearance of 20 mL/min and hepatic clearance of 5 mL/min. The total clearance of drug X would be 25 mL of plasma is cleared of drug X per minute.&#x000a0;</p>
      </sec>
      <sec id="article-91120.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Elimination kinetics play an essential role in drug clearance. In first-order kinetics, a constant fraction of the drug is cleared per unit time because the mechanisms used for elimination are not saturated. Thus, drug clearance does not vary&#x000a0;with changes in the plasma concentration of a drug when drug elimination occurs by first-order kinetics. The vast majority of drug elimination takes place by first-order kinetics. In zero-order kinetics, the same quantity of drug is eliminated per unit time because the mechanisms used for elimination are saturated.&#x000a0; In zero-order kinetics, drug clearance can vary&#x000a0;due to changes&#x000a0;in the plasma&#x000a0;concentration of a drug.<xref ref-type="bibr" rid="article-91120.r2">[2]</xref></p>
        <p>As stated in the previous examples, drug clearance plays an important role in determining drug concentration and thus dosing regimens. Steady-state plasma concentration is inversely related to the total body clearance of a drug. The dosing rate is calculated by multiplying total body clearance by a drug&#x02019;s desired steady-state concentration, assuming the drug is fully bioavailable. For patients with cardiac insufficiency, kidney and liver disease, drug clearance can be severely affected.&#x000a0; The ability of serum proteins to bind to drugs also can play a role in clearance. A decrease in serum proteins may cause an increase in free drug concentration in the plasma, thus increasing its rate of elimination from the body.<xref ref-type="bibr" rid="article-91120.r3">[3]</xref><xref ref-type="bibr" rid="article-91120.r4">[4]</xref></p>
      </sec>
      <sec id="article-91120.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>For patients with renal or hepatic disease, care is necessary to adjust dosages. In patients with severe liver disease, maintenance dosages should be reduced based on the percent of hepatic clearance of the drug.<xref ref-type="bibr" rid="article-91120.r5">[5]</xref><xref ref-type="bibr" rid="article-91120.r6">[6]</xref> Dosing in kidney disease tends to be complicated. Many drug companies provide dosage guidelines for each stage of renal disease. Dose reductions are often necessary for patients with renal disease.<xref ref-type="bibr" rid="article-91120.r7">[7]</xref>&#x000a0;The interaction of drugs with the kidney, type of kidney disease, and creatinine clearance need factor into dosing and therapy. Another factor that merits consideration is age because drug clearance decreases as&#x000a0;patients get older.<xref ref-type="bibr" rid="article-91120.r8">[8]</xref><xref ref-type="bibr" rid="article-91120.r9">[9]</xref></p>
      </sec>
      <sec id="article-91120.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The healthcare team, e.g., physicians, nurses, pharmacists, etc., needs to work together to ensure the safe and effective pharmacotherapy of their patients. Understanding the concept of drug clearance is essential when determining the dosing of medications.&#x000a0;For patients with renal, hepatic, or cardiac disease, care is often necessary to adjust drug dosages to prevent adverse drug effects. [Level 5]</p>
      </sec>
      <sec id="article-91120.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=91120&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=91120">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/91120/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=91120">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-91120.s6">
        <title>References</title>
        <ref id="article-91120.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toutain</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Bousquet-M&#x000e9;lou</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Plasma clearance.</article-title>
            <source>J Vet Pharmacol Ther</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>415</fpage>
            <page-range>415-25</page-range>
            <pub-id pub-id-type="pmid">15601437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91120.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Wadhwa</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Cascella</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Steady State Concentration</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>3</month>
            <day>6</day>
            <pub-id pub-id-type="pmid">31985925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91120.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jokanovic</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Sudhakaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kirkpatrick</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Dooley</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ryan-Atwood</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Pharmacist-led medication review in community settings: An overview of systematic reviews.</article-title>
            <source>Res Social Adm Pharm</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>661</fpage>
            <page-range>661-685</page-range>
            <pub-id pub-id-type="pmid">27665364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91120.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics in renal disease.</article-title>
            <source>Am J Med</source>
            <year>1977</year>
            <month>Apr</month>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>461</fpage>
            <page-range>461-5</page-range>
            <pub-id pub-id-type="pmid">851113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91120.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delc&#x000f2;</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tchambaz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schlienger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Drewe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kr&#x000e4;henb&#x000fc;hl</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Dose adjustment in patients with liver disease.</article-title>
            <source>Drug Saf</source>
            <year>2005</year>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>529</fpage>
            <page-range>529-45</page-range>
            <pub-id pub-id-type="pmid">15924505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91120.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgan</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Smallwood</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Clinical significance of pharmacokinetic models of hepatic elimination.</article-title>
            <source>Clin Pharmacokinet</source>
            <year>1990</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-76</page-range>
            <pub-id pub-id-type="pmid">2178850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91120.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lea-Henry</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Carland</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Stocker</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Sevastos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Clinical Pharmacokinetics in Kidney Disease: Fundamental Principles.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2018</year>
            <month>Jul</month>
            <day>06</day>
            <volume>13</volume>
            <issue>7</issue>
            <fpage>1085</fpage>
            <page-range>1085-1095</page-range>
            <pub-id pub-id-type="pmid">29934432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91120.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toto</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance.</article-title>
            <source>Curr Opin Nephrol Hypertens</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>505</fpage>
            <page-range>505-9; discussion 503-4</page-range>
            <pub-id pub-id-type="pmid">8591059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91120.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Begg</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Free drug metabolic clearance in elderly people.</article-title>
            <source>Clin Pharmacokinet</source>
            <year>2008</year>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>297</fpage>
            <page-range>297-321</page-range>
            <pub-id pub-id-type="pmid">18399712</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
